Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debin Wan

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Plos One|July 17, 2024
Correction: Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitorChuanzhen Zhang, Wei Li, Xiyuan Li, et al.
Plos One|April 20, 2022
Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitorChuanzhen Zhang, Wei Li, Xiyuan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2018
Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammationWeicang Wang, Jun Yang, Jianan Zhang, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Cancer Research|February 27, 2019
Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon TumorigenesisWeicang Wang, Jun Yang, Matthew L Edin, et al.
Journal of Advanced Research|December 30, 2022
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injuryMatthieu Leuillier, Thomas Duflot, Séverine Ménoret, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Plos One|July 17, 2024
Correction: Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitorChuanzhen Zhang, Wei Li, Xiyuan Li, et al.
Plos One|April 20, 2022
Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitorChuanzhen Zhang, Wei Li, Xiyuan Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2018
Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammationWeicang Wang, Jun Yang, Jianan Zhang, et al.
Journal of Medicinal Chemistry|June 8, 2017
Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress ResponseRevital Yefidoff-Freedman, Jing Fan, Lu Yan, et al.
Cancer Research|February 27, 2019
Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon TumorigenesisWeicang Wang, Jun Yang, Matthew L Edin, et al.
Journal of Advanced Research|December 30, 2022
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injuryMatthieu Leuillier, Thomas Duflot, Séverine Ménoret, et al.
Pageof 6